AP

Apotheek Pylyser Sofie

BE0888.396.472

Gross margin
€ 81K ↑ 7% 2025 Total € 694K
Profit
€ 58K ↑ 16% 2025 Total € 175K
EBITDA
€ 80K ↑ 7% 2025 Total € 682K
EBIT
€ 72K ↑ 9% 2025 Total € 335K
Net profit
€ 58K ↑ 16% 2025 Total € 175K
Capex
€ 3K ↑ 122% 2025 Total € 178K
Assets
€ 315K ↑ 7% 2025
Equity
€ 85K ↓ 42% 2025
Debt
€ 230K ↑ 55% 2025
Cash
€ 14K ↓ 20% 2025
Cashflow
€ 66K ↑ 12% 2025 Total € 521K
Working capital
€ 81K ↓ 44% 2025
Current ratio
1.35 ↓ 31% 2025
Quick ratio
0.79 ↓ 24% 2025
Working capital ratio
1.35 ↓ 31% 2025
Debt
€ 230K ↑ 55% 2025
Short-term debt
€ 230K ↑ 55% 2025
Long-term debt
€ 28K ↓ 55% 2012
Debt / EBITDA
2.87 ↑ 45% 2025
Solvability
26.9% ↓ 22.7 pt 2025
Long term debt ratio
0.68 ↓ 24% 2012
Gross profitability
78.6% ↑ 37.9 pt 2025
Net profitability
68.8% ↑ 34.4 pt 2025
Return On Assets (ROA)
18.49 ↑ 8% 2025
Return On Equity (ROE)
68.79 ↑ 100% 2025
Taxes
€ 15K ↑ 18% 2025 Total € 50K
Salaries and Social Security Contributions
€ 2K 2009
Dividends
€ 120K 2025
Dividend payout
206.1% 2025